Bevacizumab and neovascular age related macular degeneration
The pathogenesis of neovascular age related macular degeneration (AMD) is multifactorial including inflammation and angiogenesis leading to choroidal neovascularization (CNV). Therapy against vascular endothelial growth factor (VEGF) has revolutionized the treatment of neovascular AMD. Intravitreal...
محفوظ في:
| المؤلف الرئيسي: | El Mollayess, Georges (author) |
|---|---|
| مؤلفون آخرون: | Noureddine, Baha' N. (author), Bashshur, Ziad F. (author) |
| التنسيق: | article |
| منشور في: |
2011
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/14186 https://doi.org/10.3109/08820538.2010.545100 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.tandfonline.com/doi/abs/10.3109/08820538.2010.545100?journalCode=isio20 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Intravitreal bevacizumab in the management of neovascular age-related macular degeneration
حسب: El-Mollayess, Georges M.
منشور في: (2013) -
Bevacizumab for neovascular age-related macular degeneration (ABC trial)
حسب: Ghazi, Nicola G.
منشور في: (2014) -
Fixed-interval versus OCT-guided variable dosing of intravitreal bevacizumab in the management of neovascular age-related macular degeneration
حسب: El-Mollayess, Georges M.
منشور في: (2012) -
Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?
حسب: Ghazi, Nicola G.
منشور في: (2010) -
Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy
حسب: Ghazi, Nicola G.
منشور في: (2001)